Baird Financial Group, Inc. Edwards Lifesciences Corp Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 107,877 shares of EW stock, worth $7.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

107,877

Previous 75,066 43.71%

Holding current value

$7.06 Million

Previous $7.17 Million 38.91%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $2.77 Million - $3.09 Million	32,811 Added 43.71%	107,877 $9.96 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $6.6 Million - $8.69 Million	-90,968 Reduced 54.79%	75,066 $7.17 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $416,665 - $525,035	-6,752 Reduced 3.91%	166,034 $12.7 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $92,073 - $124,102	1,329 Added 0.78%	172,786 $12 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $841,290 - $974,806	-10,334 Reduced 5.68%	171,457 $16.2 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $2.23 Million - $2.53 Million	-29,977 Reduced 14.16%	181,791 $15 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.01 Million - $1.31 Million	-12,222 Reduced 6.57%	173,924 $14.4 Million
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $4.61 Million - $6.84 Million	53,294 Added 40.12%	186,146 $17.7 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $9.71 Million - $12.2 Million	-95,271 Reduced 41.76%	132,852 $15.6 Million
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $856,384 - $1.05 Million	8,051 Added 3.66%	228,123 $29.6 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.19 Million - $1.42 Million	-11,579 Reduced 5.0%	220,072 $24.9 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $9.07 Million - $11.3 Million	108,231 Added 87.69%	231,651 $24 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $12.6 Million - $14.6 Million	-160,599 Reduced 56.55%	123,420 $10.3 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $1.66 Million - $2.11 Million	23,102 Added 8.85%	284,019 $25.9 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $9.39 Million - $12.2 Million	139,756 Added 115.35%	260,917 $20.8 Million
Q2 2020 Oct 22, 2020	SELL	$57.54 - $76.95 $3.87 Million - $5.17 Million	-67,195 Reduced 35.67%	121,161 $8.37 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $8.31 Million - $11.1 Million	144,405 Added 328.56%	188,356 $13.8 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $880,435 - $1.36 Million	-16,799 Reduced 27.65%	43,951 $8.02 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $2.03 Million - $2.32 Million	28,250 Added 86.92%	60,750 $14.2 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $163,661 - $200,568	-2,659 Reduced 7.56%	32,500 $7.15 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $16.2 Million - $18.7 Million	-290,919 Reduced 89.22%	35,159 $6.5 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $3.71 Million - $4.97 Million	-77,572 Reduced 19.22%	326,078 $62.4 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $1.27 Million - $1.55 Million	27,279 Added 7.25%	403,650 $61.8 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $3.92 Million - $4.98 Million	-85,736 Reduced 18.55%	376,371 $64.3 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $275,925 - $333,450	-6,500 Reduced 1.39%	462,107 $67.3 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $431,218 - $550,182	-11,595 Reduced 2.41%	468,607 $65.4 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $1.23 Million - $1.43 Million	-36,316 Reduced 7.03%	480,202 $54.1 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.28 Million - $1.37 Million	35,407 Added 7.36%	516,518 $56.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	481,111	481,111 $56.9 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Edwards Lifesciences Corp Transaction History